Lei Zhang

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening

Xiaofei Chen, Yun‐Long Wu, Chun Chen et al. · Acta Pharmaceutica Sinica B · 2020 · 188 citations · Full text

Medicine, Pharmaceutical Analysis, Pharmacology +13

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 150 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model

Inhye E. Ahn, Xin Tian, David Ipe et al. · Journal of Clinical Oncology · 2020 · 103 citations · Full text

Medicine, Oncology, Pharmacology +17

Conditional Singlet Oxygen Generation through a Bioorthogonal DNA‐targeted Tetrazine Reaction

Greta Linden, Lei Zhang, Fabian Pieck et al. · Angewandte Chemie International Edition · 2019 · 97 citations

Medicine, Cancer Biology, Oncology +14

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo et al. · The Journal of Clinical Pharmacology · 2012 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +17